Literature DB >> 7859425

The overdiagnosis of Lyme disease in children residing in an endemic area.

C D Rose1, P T Fawcett, K M Gibney, R A Doughty.   

Abstract

The medical records of 227 children ages 1 to 19 years referred to the Lyme disease pediatric clinic over a 32-month period since May 1990 were reviewed. Clinico-serologic criteria for a positive diagnosis were applied. One hundred thirty-eight of 227 referred children did not fulfill those criteria and became the study population. Four subsets of patients emerged: (1) 54 patients with predominantly subjective symptoms; (2) 52 patients with objective evidence for an alternative diagnosis; (3) eight patients who had documented infection in the past and continued with symptoms after antibiotic treatment; and (4) 24 patients with a history of tick attachment or prenatal/family history of Lyme disease. Serologic testing data from commercial laboratories were available for the 54 children from the "predominantly subjective" group; 50% were negative, and 50% were borderline or positive. Ninety-two percent of these patients were negative at retesting by our enzyme-linked immunosorbent assay (ELISA) and 100% were negative by Western blot. Fifty-seven percent of these patients had received treatment prior to our evaluation. Children residing in an endemic area who present with vague symptoms are being diagnosed with and treated for Lyme disease without clinical or serologic documentation. In addition, fear in the lay community may be inducing doctors to diagnose Lyme disease in patients with symptoms that may be suggestive of an alternative diagnosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7859425     DOI: 10.1177/000992289403301105

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  11 in total

1.  Utilization of tests for Lyme disease antibody at a university hospital.

Authors:  I Nachamkin; D L Riddle; M Feldman; P H Edelstein
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 2.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 3.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

4.  Correlation of seroreactivity with response to antibiotics in pediatric Lyme borreliosis.

Authors:  P T Fawcett; C D Rosé; K M Gibney; R A Doughty
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

Review 5.  Persistent Symptoms After Treatment of Lyme Disease.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

Review 6.  Chronic Lyme disease: a review.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

7.  Implications of gender in chronic Lyme disease.

Authors:  Gary P Wormser; Eugene D Shapiro
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

8.  Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.

Authors:  M F Seidel; A Belda Domene; H Vetter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

Review 9.  Lyme disease and current aspects of immunization.

Authors:  Thomas Kamradt
Journal:  Arthritis Res       Date:  2001-09-28

10.  Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.

Authors:  Ruben Magni; Benjamin H Espina; Ketul Shah; Benjamin Lepene; Christine Mayuga; Temple A Douglas; Virginia Espina; Sally Rucker; Ross Dunlap; Emanuel F Iii Petricoin; Mary Frekko Kilavos; Donald M Poretz; Gilbert R Irwin; Samuel M Shor; Lance A Liotta; Alessandra Luchini
Journal:  J Transl Med       Date:  2015-11-04       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.